1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

United Therapeutics Corporation (UTHR) CEO Martine A Rothblatt buys 6,000 Shares

December 26, 2012 | About:

CEO of United Therapeutics Corporation (NASDAQ:UTHR) Martine A Rothblatt buys 6,000 shares of UTHR on 12/26/2012 at an average price of $52.4 a share.

United Therapeutics Corporation has a market cap of $2.67 billion; its shares were traded at around $52.63 with a P/E ratio of 10.6 and P/S ratio of 3.6.

This is the annual revenues and earnings per share of UTHR over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of UTHR.


CEO Recent Trades:



  • CEO Martine A Rothblatt bought 6,000 shares of UTHR stock on 12/26/2012 at the average price of 52.4. Martine A Rothblatt owns at least 705,602 shares after this. The price of the stock has increased by 0.44% since.
  • CEO Martine A Rothblatt bought 9,000 shares of UTHR stock on 12/21/2012 at the average price of 51.85. Martine A Rothblatt owns at least 699,602 shares after this. The price of the stock has increased by 1.5% since.

CFO Recent Trades:



  • CFO John Maxim Ferrari sold 1,550 shares of UTHR stock on 10/04/2012 at the average price of 58. The price of the stock has decreased by 9.26% since.
  • CFO John Maxim Ferrari sold 5,500 shares of UTHR stock on 09/20/2012 at the average price of 58.05. The price of the stock has decreased by 9.34% since.
  • CFO John Maxim Ferrari sold 5,500 shares of UTHR stock on 09/06/2012 at the average price of 55.69. The price of the stock has decreased by 5.49% since.
  • CFO John Maxim Ferrari sold 5,500 shares of UTHR stock on 08/16/2012 at the average price of 56.29. The price of the stock has decreased by 6.5% since.
  • CFO John Maxim Ferrari sold 5,500 shares of UTHR stock on 08/02/2012 at the average price of 53.75. The price of the stock has decreased by 2.08% since.

This is the insider trade history vs. stock price of UTHR. For the complete insider trading history of UTHR, click here.




Directors and Officers Recent Trades:



  • President & COO Roger Jeffs sold 5,000 shares of UTHR stock on 12/21/2012 at the average price of 52.51. Roger Jeffs owns at least 25,636 shares after this. The price of the stock has increased by 0.23% since.
  • EVP & General Counsel Paul A Mahon sold 6,000 shares of UTHR stock on 12/20/2012 at the average price of 52.45. Paul A Mahon owns at least 33,600 shares after this. The price of the stock has increased by 0.34% since.
  • President & COO Roger Jeffs sold 5,000 shares of UTHR stock on 12/07/2012 at the average price of 52.04. Roger Jeffs owns at least 25,636 shares after this. The price of the stock has increased by 1.13% since.
  • Director Christopher Causey sold 1,500 shares of UTHR stock on 12/06/2012 at the average price of 53. Christopher Causey owns at least 1,183 shares after this. The price of the stock has decreased by 0.7% since.
  • Director Christopher Causey sold 1,500 shares of UTHR stock on 11/26/2012 at the average price of 53.33. Christopher Causey owns at least 1,183 shares after this. The price of the stock has decreased by 1.31% since.


For the complete insider trading history of UTHR, click here.
  • CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
  • Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
  • Double Buys:: Companies that both Gurus and Insiders are buying
  • Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.

» Take a Free Trial of Premium Membership


Rating: 2.3/5 (3 votes)

Comments

Please leave your comment:


Select portfolio(s):

  • Loading...

Why you are interested?

Your selection and notes will be stored in your portfolio.

Login to add portfolio
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK